诺思格 (301333)
R&G PharmaStudies Co., Ltd.
K-Line Chart
No K-line data
Stock Details
1. Key Indicators
- Total Shares(W): 9658.13
- Circulating A-Shares(W): 5717.02
- Earnings Per Share(RMB): 1.0000
- Net Assets Per Share(RMB): 19.8894
- Operating Revenue(W RMB): 60737.04
- Total Profit(W RMB): 10981.49
- Net Profit Attributable to Parent(W RMB): 9556.68
- Net Profit Growth Rate(%): 13.21
- Weighted Return on Equity(%): 5.0800
- Operating Cash Flow Per Share(RMB): 0.3570
- Undistributed Profit Per Share(RMB): 7.9418
- Capital Reserve Per Share(RMB): 11.0296
2. Main Business
The main business covers:
- Providing comprehensive, integrated full-process clinical drug development services for global pharmaceutical companies and research institutions.
3. Company Basic Information
- Company Name: R and G PharmaStudies Co., Ltd.
- Listing Date: 2022-08-02
- Industry: Research and Experimental Development
- Address: 11th Floor, North Tower, Building B, Huatong Plaza, No.19 Chegongzhuang West Road, Haidian District, Beijing, China
- Website: www.rg-pharma.com
- Company Profile: The company, formerly known as R&G PharmaStudies (Beijing) Co., Ltd., was transformed into a foreign-invested joint-stock company in July 2015. It provides comprehensive, integrated full-process clinical drug development services for global pharmaceutical companies and research institutions.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Ningbo Kangyunfu Equity Investment Co., Ltd. | General Legal Person | 1152.00 | 20.15 |
| 2 | Ningbo Ruiguang Venture Capital Partnership (Limited Partnership) | General Legal Person | 684.00 | 11.96 |
| 3 | Harmony Growth Phase II (Yiwu) Investment Center (Limited Partnership) | General Legal Person | 333.25 | 5.83 |
| 4 | National Social Security Fund 413 Portfolio | Social Security Fund | 294.63 | 5.15 |
| 5 | National Social Security Fund 601 Portfolio | Social Security Fund | 172.03 | 3.01 |
| 6 | Noah Pioneer Mixed Securities Investment Fund Class A | Fund | 167.96 | 2.94 |
| 7 | Zhuhai Harmony Health Investment Fund (Limited Partnership) | General Legal Person | 149.65 | 2.62 |
| 8 | Ningbo Ruiming Equity Investment Co., Ltd. | General Legal Person | 115.20 | 2.02 |
| 9 | Shenzhen Capital Group Co., Ltd. | General Legal Person | 70.40 | 1.23 |
| 10 | Hong Kong Securities Clearing Company Ltd. | Northbound Capital | 69.04 | 1.21 |
5. Concept Sectors
- Artificial Intelligence
- CXO Concept
- AIGC Concept
- Innovative Drugs
- AI Healthcare
- Margin Trading & Securities Lending
- Imminent Share Unlock
- High-Performance Stock
- Growth Enterprise Board Small Cap
Remarks
- Data update date: 2026-01-01
- Data source: Public Market Information